Expanding the Psychedelic Frontier: MM120 for Anxiety
A psychedelic is being seriously studied for generalized anxiety disorder (GAD) rather than depression. A newly published phase 2b clinical trial in JAMA evaluated lysergide (MM120)—better known as LSD—for anxiety. This represents a pivotal step toward expanding psychedelic research into conditions beyond mood disorders.